Gufic Biosciences Limited have been granted patent by the Eurasian Patent office (EAPO) for its invention of "A FREEZE DRIED PARENTERAL COMPOSITION OF TIGECYCLINE AND PROCESS FOR PREPARATION THEREOF".
Tigecycline is a tetracycline antibiotic medication used for a number of bacterial infections and is used to treat certain serious infections including community acquired pneumonia (a lung infection that developed in a person who was not in the hospital), skin infections, and infections of the abdomen.
Further, EAPO member States are Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Russian Federation, Tajikistan and Turkmenistan.
Shares of GUFIC BIOSCIENCES LTD. was last trading in BSE at Rs.116.8 as compared to the previous close of Rs. 111.6. The total number of shares traded during the day was 74845 in over 1207 trades.
The stock hit an intraday high of Rs. 117.6 and intraday low of 111. The net turnover during the day was Rs. 8674569.